Epimune’s goal is to revolutionize diagnosis and monitoring of patients with disorders of the immune system. 


Using epigenetics, Epimune develops & commercializes molecular diagnostic tests for immune cell quantification from a drop of blood.


01 Feb 2024

New publication on epigenetic immune cell quantification in patients with inborn errors of immunity and secondary immune deficiencies.

For a Spanish version of this video please click here!